<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04290728</url>
  </required_header>
  <id_info>
    <org_study_id>1910-091-1071</org_study_id>
    <nct_id>NCT04290728</nct_id>
  </id_info>
  <brief_title>High-flow Nasal Oxygenation for Open Mouth</brief_title>
  <official_title>Effect of High-flow Nasal Oxygenation on Safe Apnea Time in Children With Open Mouth</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the effect of high-flow nasal oxygenation on safe apnea time for
      children undergoing general anesthesia, with their mouth open.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oxygenation via high-flow nasal cannula is gaining popularity in various clinical settings.
      It is known to increase apnea time for apneic patients including children. However, high-flow
      nasal cannula is known to be ineffective when the patient's mouth is kept open.

      When trying to intubate the patient during induction of anesthesia, the patient should be
      apneic with administration of neuromuscular blocking agent, and the mouth should be open for
      introduction of laryngoscope.

      We designed a prospective randomized controlled study to evaluate the effect of high-flow
      nasal oxygenation in the aforementioned setting for trying to intubate the patient.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 16, 2020</start_date>
  <completion_date type="Anticipated">November 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized, controlled clinical trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Apnea time</measure>
    <time_frame>Elapsed time starting from discontinuation of oxygen to the time point that pulse oximetry first reaches 92% (not to exceed 520 seconds)</time_frame>
    <description>Time required for pulse oximetry to drop to 92% after start of apnea</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>End-tidal carbon dioxide</measure>
    <time_frame>Procedure (From induction of anesthesia to end of anesthesia)</time_frame>
    <description>End-tidal carbon dioxide partial pressure during anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pulse oximetry</measure>
    <time_frame>Procedure (From induction of anesthesia to end of anesthesia)</time_frame>
    <description>Pulse oximetry during anesthesia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Non-invasive blood pressure</measure>
    <time_frame>Procedure (From induction of anesthesia to end of anesthesia)</time_frame>
    <description>Non-invasive blood pressure measured from forearm or leg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen reserve index</measure>
    <time_frame>Procedure (From induction of anesthesia to end of anesthesia)</time_frame>
    <description>Oxygen reserve index measured from finger or toe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to 100%</measure>
    <time_frame>Elapsed time starting from re-start of bag-mask ventilation at the end of apnea period to the time point that pulse oximetry first reaches 100% (estimated less than 2 minutes)</time_frame>
    <description>Elapsed time from re-start of bag-mask ventilation to recovery of pulse oximetry of 100% after apnea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minimum value of pulse oximetry</measure>
    <time_frame>Procedure (From induction of anesthesia to end of anesthesia)</time_frame>
    <description>Minimum value of pulse oximetry after re-start of bag-mask ventilation after apnea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1st value of end-tidal carbon dioxide</measure>
    <time_frame>At expiration of the first manual ventilation after the end of the apnea period (less than 520 seconds after start of apnea period)</time_frame>
    <description>First measured value of end-tidal carbon dioxide partial pressure after re-start of bag-mask ventilation after apnea</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Anesthesia, General</condition>
  <condition>Apnea</condition>
  <arm_group>
    <arm_group_label>High flow</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Apply high-flow nasal oxygenation during apnea with open mouth after adequate preoxygenation. Resume bag-mask ventilation when pulse oximetry drops to 92% or pre-set apnea time has expired.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Apply nothing during apnea with open mouth after adequate preoxygenation. Resume bag-mask ventilation when pulse oximetry drops to 92% or pre-set apnea time has expired.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Apnea with high-flow nasal cannula</intervention_name>
    <description>Application of oxygenation with high-flow nasal cannula with a rate of 2L/kg/min</description>
    <arm_group_label>High flow</arm_group_label>
    <other_name>Airvo 2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Apnea</intervention_name>
    <description>Apnea without any application of oxygenation</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children younger than 11 years old scheduled to undergo surgery under general
             anesthesia, with American Society of Anesthesiologists Physical Status 1 or 2.

        Exclusion Criteria:

          -  Refusal to enrollment from one or more of legal guardians of the patient

          -  Children who are planned to use supraglottic airway device

          -  Children with upper respiratory tract infection or pulmonary interstitial disease

          -  Preterm babies under 40 weeks of postconceptual age

          -  Children who are expected to have difficult airway for bag-mask ventilation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Tae Kim, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sang-Hwan Ji, M.D., M.S.</last_name>
    <phone>+82-2-2072-3661</phone>
    <email>taepoongshin@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin-Tae Kim, Pf.</last_name>
      <phone>+82-2-2072-3295</phone>
      <email>jintae73@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Fiadjoe JE, Nishisaki A, Jagannathan N, Hunyady AI, Greenberg RS, Reynolds PI, Matuszczak ME, Rehman MA, Polaner DM, Szmuk P, Nadkarni VM, McGowan FX Jr, Litman RS, Kovatsis PG. Airway management complications in children with difficult tracheal intubation from the Pediatric Difficult Intubation (PeDI) registry: a prospective cohort analysis. Lancet Respir Med. 2016 Jan;4(1):37-48. doi: 10.1016/S2213-2600(15)00508-1. Epub 2015 Dec 17.</citation>
    <PMID>26705976</PMID>
  </reference>
  <reference>
    <citation>Frei FJ, Ummenhofer W. Difficult intubation in paediatrics. Paediatr Anaesth. 1996;6(4):251-63. Review.</citation>
    <PMID>8827740</PMID>
  </reference>
  <reference>
    <citation>Schibler A, Hall GL, Businger F, Reinmann B, Wildhaber JH, Cernelc M, Frey U. Measurement of lung volume and ventilation distribution with an ultrasonic flow meter in healthy infants. Eur Respir J. 2002 Oct;20(4):912-8.</citation>
    <PMID>12412683</PMID>
  </reference>
  <reference>
    <citation>King W, Petrillo T, Pettignano R. Enteral nutrition and cardiovascular medications in the pediatric intensive care unit. JPEN J Parenter Enteral Nutr. 2004 Sep-Oct;28(5):334-8.</citation>
    <PMID>15449573</PMID>
  </reference>
  <reference>
    <citation>Schibler A, Yuill M, Parsley C, Pham T, Gilshenan K, Dakin C. Regional ventilation distribution in non-sedated spontaneously breathing newborns and adults is not different. Pediatr Pulmonol. 2009 Sep;44(9):851-8. doi: 10.1002/ppul.21000.</citation>
    <PMID>19672959</PMID>
  </reference>
  <reference>
    <citation>Schibler A, Henning R. Positive end-expiratory pressure and ventilation inhomogeneity in mechanically ventilated children. Pediatr Crit Care Med. 2002 Apr;3(2):124-128.</citation>
    <PMID>12780980</PMID>
  </reference>
  <reference>
    <citation>Erb T, Marsch SC, Hampl KF, Frei FJ. Teaching the use of fiberoptic intubation for children older than two years of age. Anesth Analg. 1997 Nov;85(5):1037-41.</citation>
    <PMID>9356095</PMID>
  </reference>
  <reference>
    <citation>Mir F, Patel A, Iqbal R, Cecconi M, Nouraei SA. A randomised controlled trial comparing transnasal humidified rapid insufflation ventilatory exchange (THRIVE) pre-oxygenation with facemask pre-oxygenation in patients undergoing rapid sequence induction of anaesthesia. Anaesthesia. 2017 Apr;72(4):439-443. doi: 10.1111/anae.13799. Epub 2016 Dec 30.</citation>
    <PMID>28035669</PMID>
  </reference>
  <reference>
    <citation>Lodenius Å, Piehl J, Östlund A, Ullman J, Jonsson Fagerlund M. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) vs. facemask breathing pre-oxygenation for rapid sequence induction in adults: a prospective randomised non-blinded clinical trial. Anaesthesia. 2018 May;73(5):564-571. doi: 10.1111/anae.14215. Epub 2018 Jan 13.</citation>
    <PMID>29330853</PMID>
  </reference>
  <reference>
    <citation>Humphreys S, Lee-Archer P, Reyne G, Long D, Williams T, Schibler A. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE) in children: a randomized controlled trial. Br J Anaesth. 2017 Feb;118(2):232-238. doi: 10.1093/bja/aew401.</citation>
    <PMID>28100527</PMID>
  </reference>
  <reference>
    <citation>Lyons C, Callaghan M. Uses and mechanisms of apnoeic oxygenation: a narrative review. Anaesthesia. 2019 Apr;74(4):497-507. doi: 10.1111/anae.14565. Epub 2019 Feb 19. Review.</citation>
    <PMID>30784037</PMID>
  </reference>
  <reference>
    <citation>Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care. 2005 May;50(5):604-9.</citation>
    <PMID>15871753</PMID>
  </reference>
  <reference>
    <citation>Parke R, McGuinness S, Eccleston M. Nasal high-flow therapy delivers low level positive airway pressure. Br J Anaesth. 2009 Dec;103(6):886-90. doi: 10.1093/bja/aep280. Epub 2009 Oct 20.</citation>
    <PMID>19846404</PMID>
  </reference>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>February 24, 2020</study_first_submitted>
  <study_first_submitted_qc>February 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 2, 2020</study_first_posted>
  <last_update_submitted>May 14, 2020</last_update_submitted>
  <last_update_submitted_qc>May 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>High-flow nasal cannula</keyword>
  <keyword>Preoxygenation</keyword>
  <keyword>Apnea time</keyword>
  <keyword>General anesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

